The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis

EuroIntervention 2016;12:e1385-e1385.

1. San Raffaele Scientific Institute, Milan, Italy; 2. Heart of England NHS Trust, Birmingham, United Kingdom; 3. Misericordia Hospital, Grosseto, Italy; 4. Carlo Poma Hospital, Mantua, Italy; 5. University of Ferrara, Ferrara, Italy; 6. Policlinico Casil

Aims: Bindarit (BND) is a selective inhibitor of monocyte chemotactic protein-1 (MCP-1/CCL2), which plays an important role in generating intimal hyperplasia. Our aim was to explore the e

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis